MB, Levis & Associates’s CVS Health CVS Stock Holding History

MB, Levis & Associates’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$22.9K	Buy	319 +3	+0.9%	+$231	0.01%	136
2025 Q4	$25.1K	Buy	316 +3	+1%	+$237	0.01%	133
2025 Q3	$23.6K	Buy	313 +3	+1%	+$206	0.01%	134
2025 Q2	$21.4K	Buy	310 +3	+1%	+$197	0.01%	165
2025 Q1	$20.8K	Buy	307 +3	+1%	+$180	0.01%	160
2024 Q4	$13.6K	Buy	304 +4	+1%	+$224	0.01%	175
2024 Q3	$18.9K	Sell	300 -328	-52%	-$19.1K	0.01%	164
2024 Q2	$37.1K	Buy	628 +7	+1%	+$438	0.02%	127
2024 Q1	$49.5K	Sell	621 -13	-2%	-$993	0.03%	118
2023 Q4	$50.1K	Buy	634 +5	+0.8%	+$356	0.03%	115
2023 Q3	$43.9K	Buy	629 +24	+4%	+$1.7K	0.03%	117
2023 Q2	$41.8K	Buy	605 +5	+0.8%	+$356	0.03%	126
2023 Q1	$44.6K	Hold	600	–	–	0.03%	116
2022 Q4	$55.9K	Buy	+600	New	+$57.9K	0.04%	100

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MB, Levis & Associates's CVS Position: Q1 2026 in Review

MB, Levis & Associates increased its CVS Health (CVS) stake by 0.95% in Q1 2026, buying an estimated $231 and bringing the position to 319 shares worth $22.9K. The position accounts for 0.01% of the portfolio, ranked #136.

MB, Levis & Associates first reported a position in CVS in Q4 2022 and has held it in 14 quarters since. The position peaked at $55.9K in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

MB, Levis & Associates held 319 shares of CVS Health worth $22.9K as of Q1 2026.
MB, Levis & Associates bought 3 CVS Health shares in Q1 2026, an estimated $231.
CVS Health made up 0.01% of MB, Levis & Associates's portfolio in Q1 2026, its #136 holding.
MB, Levis & Associates first reported a position in CVS Health in Q4 2022 and has held it in 14 quarters since.
MB, Levis & Associates's CVS Health position peaked at $55.9K in Q4 2022.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on MB, Levis & Associates's 13F filing for Q1 2026, filed 8 Apr 2026.